{"title":"Sigma-1 receptor activation ameliorates age-related postoperative cognitive dysfunction by attenuating endoplasmic reticulum stress and neuroinflammation","authors":"Yabo Hao , Rui Hao , Kai Lu , Yun He , Zhao Xu","doi":"10.1016/j.intimp.2025.115677","DOIUrl":null,"url":null,"abstract":"<div><div>Postoperative Cognitive Dysfunction (POCD), a key phenotype within the broader spectrum of Postoperative Neurocognitive Disorders (PND), represents a significant neurological complication, predominantly affecting elderly individuals and resulting in cognitive impairment and diminished quality of life. The Sigma-1 receptor (Sigma-1R), a critical modulator of cellular stress endowed with neuroprotective properties, has emerged as a potential therapeutic target. This investigation aimed to elucidate the role of Sigma-1R in age-related susceptibility to POCD and to assess the therapeutic efficacy of the Sigma-1R agonist, PRE-084. Employing an exploratory laparotomy mouse model of POCD, we evaluated age-dependent variations in hippocampal Sigma-1R expression, its specific cellular localization, and the effects of PRE-084 administration on cognitive performance and associated molecular pathways in aged mice. Our findings revealed significantly lower basal hippocampal Sigma-1R levels in aged mice compared to their adult counterparts. Subsequent to surgical intervention, adult mice demonstrated a robust upregulation of Sigma-1R, which correlated with preserved cognitive function. In contrast, aged mice exhibited a blunted Sigma-1R response (a non-significant trend towards an increase), correlating with more pronounced cognitive deficits. Immunohistochemical analysis confirmed predominant Sigma-1R expression within hippocampal neurons. Post-surgical administration of PRE-084 to aged mice resulted in a substantial amelioration of cognitive function, as assessed by the Morris water maze. These salutary effects were associated with an attenuation of endoplasmic reticulum (ER) stress, evidenced by reduced levels of BIP and p-eIF2α, mitigation of neuroinflammation, indicated by decreased microglial and astrocytic activation, inhibition of NF-κB activation, and promotion of CREB phosphorylation. In conclusion, this study underscores the pivotal role of a differential Sigma-1R response to surgical stress in the pathogenesis of age-related POCD. PRE-084 demonstrates promise as a therapeutic agent, exerting neuroprotection by alleviating neuronal ER stress, which in turn curtails secondary neuroinflammation and recalibrates critical NF-κB and CREB signaling pathways.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"167 ","pages":"Article 115677"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576925016686","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Postoperative Cognitive Dysfunction (POCD), a key phenotype within the broader spectrum of Postoperative Neurocognitive Disorders (PND), represents a significant neurological complication, predominantly affecting elderly individuals and resulting in cognitive impairment and diminished quality of life. The Sigma-1 receptor (Sigma-1R), a critical modulator of cellular stress endowed with neuroprotective properties, has emerged as a potential therapeutic target. This investigation aimed to elucidate the role of Sigma-1R in age-related susceptibility to POCD and to assess the therapeutic efficacy of the Sigma-1R agonist, PRE-084. Employing an exploratory laparotomy mouse model of POCD, we evaluated age-dependent variations in hippocampal Sigma-1R expression, its specific cellular localization, and the effects of PRE-084 administration on cognitive performance and associated molecular pathways in aged mice. Our findings revealed significantly lower basal hippocampal Sigma-1R levels in aged mice compared to their adult counterparts. Subsequent to surgical intervention, adult mice demonstrated a robust upregulation of Sigma-1R, which correlated with preserved cognitive function. In contrast, aged mice exhibited a blunted Sigma-1R response (a non-significant trend towards an increase), correlating with more pronounced cognitive deficits. Immunohistochemical analysis confirmed predominant Sigma-1R expression within hippocampal neurons. Post-surgical administration of PRE-084 to aged mice resulted in a substantial amelioration of cognitive function, as assessed by the Morris water maze. These salutary effects were associated with an attenuation of endoplasmic reticulum (ER) stress, evidenced by reduced levels of BIP and p-eIF2α, mitigation of neuroinflammation, indicated by decreased microglial and astrocytic activation, inhibition of NF-κB activation, and promotion of CREB phosphorylation. In conclusion, this study underscores the pivotal role of a differential Sigma-1R response to surgical stress in the pathogenesis of age-related POCD. PRE-084 demonstrates promise as a therapeutic agent, exerting neuroprotection by alleviating neuronal ER stress, which in turn curtails secondary neuroinflammation and recalibrates critical NF-κB and CREB signaling pathways.
期刊介绍:
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.